202 related articles for article (PubMed ID: 8097537)
1. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
[TBL] [Abstract][Full Text] [Related]
2. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability.
Lin CH; Haadsma-Svensson SR; Phillips G; McCall RB; Piercey MF; Smith MW; Svensson K; Carlsson A; Chidester CG; Von Voigtlander PF
J Med Chem; 1993 Jul; 36(15):2208-18. PubMed ID: 8340922
[TBL] [Abstract][Full Text] [Related]
4. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 5-HT1A and dopamine D2 pharmacophores. X-ray structures and affinities of conformationally constrained ligands.
Chidester CG; Lin CH; Lahti RA; Haadsma-Svensson SR; Smith MW
J Med Chem; 1993 May; 36(10):1301-15. PubMed ID: 8496900
[TBL] [Abstract][Full Text] [Related]
6. C-9 and N-substituted analogs of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3- propyl-1H-benz[e]indole-9-carboxamide: 5-HT1A receptor agonists with various degrees of metabolic stability.
Haadsma-Svensson SR; Svensson K; Duncan N; Smith MW; Lin CH
J Med Chem; 1995 Feb; 38(4):725-34. PubMed ID: 7861420
[TBL] [Abstract][Full Text] [Related]
7. (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists.
Stjernlöf P; Gullme M; Elebring T; Andersson B; Wikström H; Lagerquist S; Svensson K; Ekman A; Carlsson A; Sundell S
J Med Chem; 1993 Jul; 36(15):2059-65. PubMed ID: 8340910
[TBL] [Abstract][Full Text] [Related]
8. Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.
Romero AG; Leiby JA; McCall RB; Piercey MF; Smith MW; Han F
J Med Chem; 1993 Jul; 36(15):2066-74. PubMed ID: 8101876
[TBL] [Abstract][Full Text] [Related]
9. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
10. cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.
Cruse SF; Lear J; Klein CL; Andersen PH; Dick RM; Crider AM
J Pharm Sci; 1993 Mar; 82(3):334-9. PubMed ID: 8095545
[TBL] [Abstract][Full Text] [Related]
11. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists.
Stjernlöf P; Elebring T; Nilsson J; Andersson B; Lagerkvist S; Svensson K; Ekman A; Carlsson A; Wikström H
J Med Chem; 1994 Sep; 37(20):3263-73. PubMed ID: 7932553
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.
Ennis MD; Stjernlöf P; Hoffman RL; Ghazal NB; Smith MW; Svensson K; Wikström H; Haadsma-Svensson SR; Lin CH
J Med Chem; 1995 Jun; 38(12):2217-30. PubMed ID: 7783153
[TBL] [Abstract][Full Text] [Related]
13. 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists.
Wikström H; Andersson B; Elebring T; Lagerkvist S; Hallnemo G; Pettersson I; Jovall PA; Svensson K; Ekman A; Carlsson A
J Med Chem; 1992 Oct; 35(22):3984-90. PubMed ID: 1433207
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.
Hammarberg E; Nordvall G; Leideborg R; Nylöf M; Hanson S; Johansson L; Thorberg SO; Tolf BR; Jerning E; Svantesson GT; Mohell N; Ahlgren C; Westlind-Danielsson A; Csöregh I; Johansson R
J Med Chem; 2000 Jul; 43(15):2837-50. PubMed ID: 10956192
[TBL] [Abstract][Full Text] [Related]
15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
17. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
[TBL] [Abstract][Full Text] [Related]
18. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
Millan MJ; Cussac D; Gobert A; Lejeune F; Rivet JM; Mannoury La Cour C; Newman-Tancredi A; Peglion JL
J Pharmacol Exp Ther; 2004 Jun; 309(3):903-20. PubMed ID: 14978194
[TBL] [Abstract][Full Text] [Related]
19. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
[TBL] [Abstract][Full Text] [Related]
20. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
